Prof. Janet Dunn
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes (NCT04997811) | Prof. Janet Dunn | 2021-12-21 |
Track Prof. Janet Dunn automatically
Every clearance here is in the API, with alerts when new ones post.